SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 43 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $7,423 | +43.9% | 6,511 | +89.3% | 0.00% | – |
Q1 2023 | $5,160 | +215.6% | 3,440 | +213.6% | 0.00% | – |
Q4 2022 | $1,635 | -91.8% | 1,097 | -91.6% | 0.00% | – |
Q3 2022 | $20,000 | -35.5% | 13,114 | -2.6% | 0.00% | – |
Q2 2022 | $31,000 | 0.0% | 13,463 | -1.1% | 0.00% | – |
Q1 2022 | $31,000 | -76.2% | 13,618 | -39.2% | 0.00% | – |
Q4 2021 | $130,000 | +1081.8% | 22,402 | +2120.2% | 0.00% | – |
Q3 2021 | $11,000 | +57.1% | 1,009 | +45.4% | 0.00% | – |
Q2 2021 | $7,000 | -77.4% | 694 | -66.9% | 0.00% | – |
Q1 2021 | $31,000 | – | 2,099 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Duquesne Family Office | 100,000 | $231,000 | 0.01% |
FNY Investment Advisers, LLC | 3,500 | $8,000 | 0.01% |
LEO BROKERAGE, LLC | 14,845 | $34,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 37,900 | $88,000 | 0.00% |
UBS Group AG | 13,618 | $31,000 | 0.00% |
RHUMBLINE ADVISERS | 16,169 | $37,000 | 0.00% |
Ellevest, Inc. | 19 | $0 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 62,184 | $144,000 | 0.00% |
FMR LLC | 179 | $0 | 0.00% |
AMERICAN INTERNATIONAL GROUP, INC. | 10,375 | $24,000 | 0.00% |